Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples